These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23741347)

  • 41. Phenotypic expression and clinical outcomes in a South Asian PRKAG2 cardiomyopathy cohort.
    Ahamed H; Balegadde AV; Menon S; Menon R; Ramachandran A; Mathew N; Natarajan KU; Nair IR; Kannan R; Shankar M; Mathew OK; Nguyen TT; Gupta R; Stawiski EW; Ramprasad VL; Seshagiri S; Phalke S
    Sci Rep; 2020 Nov; 10(1):20610. PubMed ID: 33244021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrafamilial Phenotypical Variability Linked to PRKAG2 Mutation-Family Case Report and Review of the Literature.
    Marcu AS; Vătăşescu R; Onciul S; Rădoi V; Jurcuţ R
    Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for a patient presenting with a PRKAG2 mutation.
    Austin SL; Chiou A; Sun B; Case LE; Govendrageloo K; Hansen P; Kishnani PS
    Mol Genet Metab; 2017; 120(1-2):96-100. PubMed ID: 27692944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wolff-Parkinson-White Syndrome with Ventricular Hypertrophy in a Brazilian Family.
    van der Steld LP; Campuzano O; Pérez-Serra A; Moura de Barros Zamorano M; Sousa Matos S; Brugada R
    Am J Case Rep; 2017 Jul; 18():766-776. PubMed ID: 28690312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical, electrocardiographic, and electrophysiologic characteristics of patients with a fasciculoventricular pathway: the role of PRKAG2 mutation.
    Sternick EB; Oliva A; Gerken LM; Magalhães L; Scarpelli R; Correia FS; Rego S; Santana O; Brugada R; Wellens HJ
    Heart Rhythm; 2011 Jan; 8(1):58-64. PubMed ID: 20888928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.
    Oliveira SM; Ehtisham J; Redwood CS; Ostman-Smith I; Blair EM; Watkins H
    J Mol Cell Cardiol; 2003 Oct; 35(10):1251-5. PubMed ID: 14519435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atrial Flutter in PRKAG2 Syndrome: Clinical and Electrophysiological Characteristics.
    Magalhães EFS; Magalhães LP; Pinheiro JO; Guabiru AT; Aras R
    Arq Bras Cardiol; 2022 Sep; 119(5):681-8. PubMed ID: 36102422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Embryonic expression of AMPK γ subunits and the identification of a novel γ2 transcript variant in adult heart.
    Pinter K; Grignani RT; Czibik G; Farza H; Watkins H; Redwood C
    J Mol Cell Cardiol; 2012 Sep; 53(3):342-9. PubMed ID: 22683324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left ventricular non-compaction cardiomyopathy associated with the PRKAG2 mutation.
    Zhang J; Han X; Lu Q; Feng Y; Ma A; Wang T
    BMC Med Genomics; 2022 Oct; 15(1):214. PubMed ID: 36221081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and clinical characteristics of Danon disease among patients with left ventricular hypertrophy and concomitant electrocardiographic preexcitation.
    Liu Y; Chen X; Wang F; Liang Y; Deng H; Liao H; Zhang Q; Zhang B; Zhan X; Fang X; Shehata M; Wang X; Xue Y; Wu S
    Mol Genet Genomic Med; 2019 May; 7(5):e638. PubMed ID: 30929317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome.
    Miyamoto L
    J Med Invest; 2018; 65(1.2):1-8. PubMed ID: 29593177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations.
    Wolf CM; Arad M; Ahmad F; Sanbe A; Bernstein SA; Toka O; Konno T; Morley G; Robbins J; Seidman JG; Seidman CE; Berul CI
    Circulation; 2008 Jan; 117(2):144-54. PubMed ID: 18158359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.
    Gollob MH; Green MS; Tang AS; Roberts R
    Curr Opin Cardiol; 2002 May; 17(3):229-34. PubMed ID: 12015471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of G100S mutation in PRKAG2 causes Wolff-Parkinson-White syndrome in zebrafish.
    Zhang BL; Ye Z; Xu RL; You XH; Qin YW; Wu H; Cao J; Zhang JL; Zheng X; Zhao XX
    Clin Genet; 2014 Sep; 86(3):287-91. PubMed ID: 23992123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fasciculoventricular accessory pathway masked extensive atrioventricular conduction system disease in a patient with PRKAG2 syndrome.
    Gong F; Yang L; Liu Q
    Ann Noninvasive Electrocardiol; 2024 Jul; 29(4):e13134. PubMed ID: 38937983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.
    Arbustini E; Fasani R; Morbini P; Diegoli M; Grasso M; Dal Bello B; Marangoni E; Banfi P; Banchieri N; Bellini O; Comi G; Narula J; Campana C; Gavazzi A; Danesino C; Viganò M
    Heart; 1998 Dec; 80(6):548-58. PubMed ID: 10065021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rare forms of preexcitation: a case study and brief overview of familial forms of preexcitation.
    Koneru JN; Wood MA; Ellenbogen KA
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):e82-7. PubMed ID: 22895604
    [No Abstract]   [Full Text] [Related]  

  • 59. Atrial Lesions in a Pedigree With
    Chen S; Lin Y; Zhu Y; Geng L; Cui C; Li Z; Liu H; Chen H; Ju W; Chen M
    Front Cardiovasc Med; 2022; 9():840337. PubMed ID: 35360035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
    Kubo T; Ochi Y; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yoshimitsu M; Higuchi K; Takenaka T; Nakajima K; Togawa T; Tsukimura T; Sano S; Tei C; Sakuraba H; Kitaoka H
    J Cardiol; 2017 Jan; 69(1):302-307. PubMed ID: 27554049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.